» Articles » PMID: 28500865

Dihydromyricetin Ameliorates Atherosclerosis in LDL Receptor Deficient Mice

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2017 May 14
PMID 28500865
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Dihydromyricetin, the most abundant flavonoid in Ampelopsis grossedentata, exerts numerous pharmacological activities, including anti-inflammatory, antioxidant, hepatoprotective, and lipid regulatory activities; however, its protective effect against atherosclerosis remains poorly understood. The aim of the present study was to evaluate the effects of dihydromyricetin on high fat diet (HFD)-induced atherosclerosis using LDL receptor deficient (LDLr) mice.

Methods: Blood samples were collected for determination of serum lipid profiles, oxidized LDL (ox-LDL) and pro-inflammatory cytokines. Histology, hepatic lipid content, quantification of atherosclerosis, assessment of oxidative stress and inflammation were performed on liver and aorta samples by molecular biology methods. The effects of dihydromyricetin on ox-LDL-induced human umbilical vein endothelial cells (HUVECs) dysfunction and foam cell formation were further studied.

Results: (1) Dihydromyricetin ameliorated hyperlipidemia, reduced serum ox-LDL, IL-6 and TNF-α levels in HFD-fed LDLr mice. Moreover, (2) dihydromyricetin suppressed hepatic lipid accumulation and increased protein expressions of PPARα, LXRα and ABCA1. (3) It inhibited atherosclerotic lesion formation and favoured features of plaque stability. (4) Dihydromyricetin prevented hepatic and aortic inflammation as evidenced by the reduced IL-6 and TNF-α mRNA expression; (5) it prevented hepatic and aortic oxidative stress by normalizing activities of antioxidant enzymes in the liver and suppressing reactive oxygen species generation and NOX2 protein expression in both liver and aorta; (6) it inhibited oxLDL-induced injury, monocytes adhesion and oxidative stress in HUVECs and (7) inhibited macrophage foam cell formation and enhanced cholesterol efflux.

Conclusions: These findings suggest that dihydromyricetin could reduce atherosclerosis via its pleiotropic effects, including improvement of endothelial dysfunction, inhibition of macrophage foam cell formation, amelioration of lipid profiles, anti-inflammatory action and anti-oxidative effect.

Citing Articles

Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway.

Zhou X, Liu X, Yi Y, Chen S, Zhang Y, Fan W Int J Mol Sci. 2025; 26(5).

PMID: 40076792 PMC: 11900051. DOI: 10.3390/ijms26052169.


Molecular insight of miRNA-217 role in the pathogenesis of myocardial infarction: Promising diagnostic biomarker and therapeutic target.

Zaafan M, Abdelhamid A Noncoding RNA Res. 2024; 10:192-197.

PMID: 39430606 PMC: 11490675. DOI: 10.1016/j.ncrna.2024.09.007.


Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy.

Hu Q, Li C, Zhang T, Yi L, Shan Y, Ma X Lipids Health Dis. 2024; 23(1):279.

PMID: 39227809 PMC: 11370113. DOI: 10.1186/s12944-024-02263-1.


Effect of Fermented on Egg Quality, Nutrition, and Flavor by Gut Bacterial Mediation.

Zhou M, Zheng L, Geng T, Wang Y, Peng M, Hu F Animals (Basel). 2023; 13(23).

PMID: 38067029 PMC: 10705669. DOI: 10.3390/ani13233678.


Beneficial effects of flavonoids on animal models of atherosclerosis: A systematic review and meta-analysis.

Liao G, Liu W, Dai Y, Shi X, Liu Y, Li D iScience. 2023; 26(11):108337.

PMID: 38026172 PMC: 10665821. DOI: 10.1016/j.isci.2023.108337.